Enbiosis Biotechnologies
Clinical trials sponsored by Enbiosis Biotechnologies, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- AI-Crafted diet supplement takes on type 2 diabetes Results expected Mar 2027 (estimated)
- Could a simple food supplement tame ulcerative colitis? Results expected May 2027 (estimated)
-
AI-Crafted diet supplement takes on type 2 diabetes
Disease control Recruiting nowThis study tests whether a special nutritional supplement, designed using artificial intelligence, can help adults with type 2 diabetes lower their blood sugar over 24 weeks. One hundred participants will receive either the active supplement or a placebo, alongside their usual di…
Sponsor: ENBIOSIS BIOTECHNOLOGIES • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a simple food supplement tame ulcerative colitis?
Disease control Recruiting nowThis study tests a once-daily food supplement designed to improve gut bacteria in people with mild-to-moderate ulcerative colitis. About 162 adults will take either the supplement or a placebo for 24 weeks, alongside their usual treatment. The goal is to see if the supplement hel…
Sponsor: ENBIOSIS BIOTECHNOLOGIES • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC